JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchert, R.
Right arrow Articles by Clausen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchert, R.
Right arrow Articles by Clausen, M.
Journal of Nuclear Medicine Vol. 47 No. 1 38-42
© 2006 by Society of Nuclear Medicine


Clinical Investigation

Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?

Ralph Buchert, PhD1, Oliver Schulze, PhD1, Florian Wilke1, Georg Berding, MD2, Rainer Thomasius, MD3, Kay Petersen, PhD3, Winfried Brenner, MD1 and Malte Clausen, MD1

1 Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2 Department of Nuclear Medicine, University School of Medicine Hannover, Hannover, Germany; and 3 Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Correspondence: For correspondence or reprints contact: Ralph Buchert, PhD, Department of Nuclear Medicine, University Hospital Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany. E-mail: buchert{at}uke.uni-hamburg.de

PET and SPECT have suggested that there is an age-related decline of up to 10% per decade in the availability of brain serotonin transporter (SERT) in healthy subjects, starting as early as the age of 20 y. The aim of the present study was to verify these findings in young subjects. Methods: The equilibrium specific-to-nonspecific partition coefficient V''3 of the SERT ligand 11C-(+)McN5652 was obtained for 29 healthy subjects aged 18–33 y. V''3 was tested for age dependence by linear regression analysis using both a volumes-of-interest approach and voxel-based statistical parametric mapping. The sex of the subject and the season of year were considered nuisance variables. Results: Age had no significant effect on V''3. The power for the detection of an age-related decline in V''3 of the magnitude reported previously was 0.917. Conclusion: These findings indicate that age is not a relevant confounding factor for SERT availability as measured by 11C-(+)McN5652 PET in healthy adults up to the age of about 35 y.

Key Words: serotonin transporter • age • PET • (+)McN5652




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
N. Praschak-Rieder, M. Willeit, A. A. Wilson, S. Houle, and J. H. Meyer
Seasonal Variation in Human Brain Serotonin Transporter Binding
Arch Gen Psychiatry, September 1, 2008; 65(9): 1072 - 1078.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.